THIOVIR Trademark Information

Trademark by Adventrx Pharmaceuticals, Inc.

Pharmaceutical preparations for treating viral infections caused by a virus having a polymerase gene conserved in the pyrophosphate binding site, namely HIV (human immunodeficiency virus), HSV (herpes simplex virus), CMV (cytomegalovirus), HPV (human papilloma virus), West Nile Virus, and Influenza Virus, including Influenza Virus Type A

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: THIOVIR
Status/Status Date:
ABANDONED - AFTER INTER-PARTES DECISION
1/27/2009
Serial Number: 78802680
Filing Date: 1/30/2006
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical preparations for treating viral infections caused by a virus having a polymerase gene conserved in the pyrophosphate binding site, namely HIV (human immunodeficiency virus), HSV (herpes simplex virus), CMV (cytomegalovirus), HPV (human papilloma virus), West Nile Virus, and Influenza Virus, including Influenza Virus Type A
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 9/26/2006
Last Applicant/Owner:
Adventrx Pharmaceuticals, Inc.
San Diego, CA 92121
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
6725 MESA RIDGE RD STE 100
SAN DIEGO, CA 92121-2924
Current Status:
ABANDONED - AFTER INTER-PARTES DECISION
1/27/2009
Correspondent Search:
ADVENTRX PHARMACEUTICALS, INC. is a correspondent of THIOVIR trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on